Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $13.2750 (3.71%) ($13.2750 - $13.2750) on Fri. Mar. 19, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.75% (three month average) | RSI | 60 | Latest Price | $13.2750(3.71%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 1% a day on average for past five trading days. | Weekly Trend | BCRX advances 6.7% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(44%) IBB(39%) IWO(37%) IWC(35%) IWM(35%) | Factors Impacting BCRX price | BCRX will decline at least -3.375% in a week (0% probabilities). VIXM(-20%) UUP(-15%) VXX(-7%) IGOV(-7%) TBT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.375% (StdDev 6.75%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $13.16(0.87%) | 10 Day Moving Average | $12.85(3.31%) | 20 Day Moving Average | $12.11(9.62%) | To recent high | -2.6% | To recent low | 88.4% | Market Cap | $2.342b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |